DenmarkDenmark

Novozymes sets sail for maritime biofuels

23.12.2011

Copenhagen - An alliance of giants will take a thorough look into biofuels for the maritime sector. The leading enzyme producer Novozymes will team up with parts of the Danish shipping industry, including the world’s largest shipping company, A.P. Moller - Maersk. The newly established alliance will work on converting biomass into sugar and onward into biofuels that can be utilised in the maritime sector. “We've been working to develop the biotechnological solutions that enable biomass to be converted into sugar and sustainable bioethanol for land transportation for many years", said Lars Hansen, Vice President of Region Europe at Novozymes. "It's therefore natural for us to contribute our knowledge to this new project."
The project is to be headed by Professor Claus Felby of the University of Copenhagen and is set to run for 5 years. Other participants in the project include DTU (the Technical University of Denmark), Haldor Topsøe, MAN Diesel & Turbo and DONG Energy.
The maritime sector accounts for approximately 10% of global transport energy consumption. Maritime transportation represents global man-made CO2 emissions equivalent to the carbon footprint of a country such as Germany, says Novozymes.

DenmarkDenmark

04.11.2010

Copenhagen – Genmab A/S is planning to reduce its total number of staff by 33, lowering the number of employees there to 180. The antibody developer estimates the reorganisation will yield savings of around EUR 5.6m (DKK30m)...

DenmarkDenmark

04.11.2010

Copenhagen – Zealand Pharma A/S, a bio­pharmaceutical company specialised in the development of peptide-based drugs for the treatment of metabolic diseases, is planning to go public on the NASDAQ OMX in Copenhagen. The initial...

DenmarkDenmark

02.11.2010

Glostrup – Danish cancer diagnostics company Dako A/S has partnered with CRO Quintiles GmbH for the co-development of targeted therapies and companion diagnostics. Under the non-exclusive alliance, Dako and Quintiles will offer...

DenmarkDenmark

16.09.2010

Copenhagen – Bavarian Nordic is facing losses due to behind-schedule production of its smallpox vaccine. The firm says it now has a grip on problems that had hampered deliveries, but that they would still not fulfill expectations...

DenmarkDenmark

11.07.2010

London/Copenhagen – British drugmaker GlaxoSmithKline has changed the conditions of its EUR1.2bn licensing agreement with Danish antibody specialist Genmab. GSK announced it will take over responsibility for developing Genmab’s...

DenmarkDenmark

10.07.2010

Copenhagen/Washington – Citing the report “The Future of Industrial Biorefineries” during a keynote address at the BIO World Congress conference in Washington at the end of June, the CEO of Danish biotech Novozymes, Steen...

DenmarkDenmark

10.07.2010

A week before the UK’s National Institute for Clinical Excellence (NICE) refused reimbursing for GlaxoSmithKline’s leukemia drug Azerra (ofatumumab), Danish licenser Genmab A/S announced the resignation of CEO Lisa Drakeman....

DenmarkDenmark

05.07.2010

London/Copenhagen – British drugmaker GlaxoSmithKline has changed the conditions of its EUR1.2bn licensing agreement with Danish antibody specialist Genmab. GSK announced it will take over responsibility for developing Genmab’s...

DenmarkDenmark

28.05.2010

Baegsvard – Danish enzyme specialist Novozyme has signed an agreement with the world’s third-largest oil refinery firm Sinopec, to provide enzymes for a cellulosic ethanol demonstration plant in China. The new plant, which will...

Displaying results 21 to 30 out of 194

< Previous 21-30 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-denmark/browse/2/article/novozymes-sets-sail-for-maritime-biofuels.html

Print Magazine

Event Video

All videos

Events

All Events

Stock list

All quotes

TOP

  • VITA 344.32 EUR6.67%
  • MORPHOSYS74.44 EUR4.04%
  • STRATEC BIOMEDICAL39.84 EUR3.94%

FLOP

  • CYTOS0.16 CHF-5.88%
  • CO.DON2.75 EUR-3.17%
  • ADDEX3.30 CHF-2.94%

TOP

  • BIOFRONTERA2.90 EUR31.2%
  • VITA 344.32 EUR8.0%
  • BB BIOTECH157.70 EUR7.3%

FLOP

  • PAION2.24 EUR-30.0%
  • CYTOS0.16 CHF-27.3%
  • MAGFORCE5.90 EUR-17.5%

TOP

  • SANTHERA85.50 CHF2335.9%
  • CO.DON2.75 EUR192.6%
  • PAION2.24 EUR163.5%

FLOP

  • CYTOS0.16 CHF-95.8%
  • THERAMETRICS0.08 CHF-42.9%
  • 4SC0.97 EUR-42.6%

No liability assumed, Date: 23.10.2014


Current issue

All issues

Product of the week

Products